ADOREYES at ESI Toronto 2026: ExoScript MD™ Dual-Exosome System for Med Spas

ADOREYES Exhibiting at ESI Toronto | Booth 1222

Introducing ExoScript MD™ Dual-Exosome System

ADOREYES will be exhibiting at ESI Toronto, presenting ExoScript MD™, a clinic-exclusive dual-exosome system developed through Canadian research and proprietary ingredient innovation.

Designed for integration into modern aesthetic practices, ExoScript MD™ combines:
• ExoScript MD Booster (professional-use concentrate)
• ExoScript MD Biomimetic Renewal Serum (homecare support)

This system is structured to support post-procedure care, with a focus on formulation precision, safety within cosmetic scope, and compatibility with existing treatment protocols.

What to Expect at Our Booth

Visit us to explore:
• how exosome technologies differ by source, processing, and formulation design
• how dual-exosome systems compare to peptides and growth factor analogs
• key considerations for evaluating product claims and compliance
• practical integration into treatments such as microneedling, laser, and advanced aesthetic services

Our team will also provide guidance on incorporating ExoScript MD™ into both in-clinic protocols and homecare, with an emphasis on consistency, efficiency, and patient experience.

Live Clinical Session

Join our advanced clinical class for a deeper, structured overview of exosome technologies and protocol integration.

🗓 April 26
⏰ 3:00 PM
📍 Room 205-D

Visit Us

📍 Booth 1222
📅 April 26–27 | ESI Toronto

This is an opportunity to explore a more structured, clinic-owned approach to exosome integration. Designed to fit seamlessly into existing workflows without added complexity.